BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 20830690)

  • 101. New immunohistochemical markers in the differential diagnosisof nonsmall cell lung carcinoma.
    Bir F; Çeliker D; Evyapan BF; Yaren A; Edirne T
    Turk J Med Sci; 2016 Dec; 46(6):1854-1861. PubMed ID: 28081338
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Thyroid transcription factor-1 distinguishes metastatic pulmonary from well-differentiated neuroendocrine tumors of other sites.
    Oliveira AM; Tazelaar HD; Myers JL; Erickson LA; Lloyd RV
    Am J Surg Pathol; 2001 Jun; 25(6):815-9. PubMed ID: 11395561
    [TBL] [Abstract][Full Text] [Related]  

  • 103. A comprehensive immunohistochemistry algorithm for the histological subtyping of small biopsies obtained from non-small cell lung cancers.
    Koh J; Go H; Kim MY; Jeon YK; Chung JH; Chung DH
    Histopathology; 2014 Dec; 65(6):868-78. PubMed ID: 25130792
    [TBL] [Abstract][Full Text] [Related]  

  • 104. [Analysis of nuclear matrix protein in human lung cancer cells].
    Yamazaki H; Kaneko M; Sasajima T; Kubo Y
    Nihon Kyobu Geka Gakkai Zasshi; 1997 Mar; 45(3):401-2. PubMed ID: 9235358
    [No Abstract]   [Full Text] [Related]  

  • 105. TTF-1 and Napsin-A Are Not Markers for Biliary Phenotype: An Immunohistochemical Study of Gallbladder Adenocarcinomas.
    Roy M; Jain D; Yadav R; Mathur SR; Iyer VK
    Am J Surg Pathol; 2015 Dec; 39(12):1742-4. PubMed ID: 26559378
    [No Abstract]   [Full Text] [Related]  

  • 106. A word of caution regarding napsin A expression in squamous cell carcinomas of the lung.
    Ordóñez NG
    Am J Surg Pathol; 2012 Mar; 36(3):396-401. PubMed ID: 22198009
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Long-term survival after incomplete resection of immunohistochemically diagnosed T0N1 lung cancer: report of a case.
    Izumi Y; Mukai M; Kikuchi K; Kobayashi K
    Surg Today; 2006; 36(3):270-3. PubMed ID: 16493539
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Utility of thyroid transcription factor-1 expression in the differential diagnosis of metastatic adenocarcinoma of serous effusion specimens prepared using the cell transfer technique.
    Jan IS; Chung PF; Weng MH; Huang MS; Lee YT; Kuo SH
    J Formos Med Assoc; 2006 Sep; 105(9):695-700. PubMed ID: 16959616
    [TBL] [Abstract][Full Text] [Related]  

  • 109. TTF-1 in embryonal tumors: an immunohistochemical study of 117 cases.
    Galliani CA; Bisceglia M; Lastilla G; Parafioriti A; Vita G; Rosai J
    Am J Surg Pathol; 2011 Sep; 35(9):1422-5. PubMed ID: 21836486
    [No Abstract]   [Full Text] [Related]  

  • 110. Immunohistochemical analysis and comparison of napsin A, TTF1, SPA and CK7 expression in primary lung adenocarcinoma.
    Jin L; Liu Y; Wang X; Qi X
    Biotech Histochem; 2018; 93(5):364-372. PubMed ID: 29956575
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Pulmonary metastasis of a papillary thyroid carcinoma and primary lung adenocarcinoma: two coincident carcinomas at the same location.
    Xue L; Luan Z; Liu Y; Zou S; Jiang J; Wu N; Lu N; Lin D
    Diagn Pathol; 2013 Feb; 8():26. PubMed ID: 23414265
    [TBL] [Abstract][Full Text] [Related]  

  • 112. The role of Napsin-A and Desmocollin-3 in classifying poorly differentiating non-small cell lung carcinoma.
    Ezzat Nel-S; Tahoun N
    J Egypt Natl Canc Inst; 2016 Mar; 28(1):13-22. PubMed ID: 26710975
    [TBL] [Abstract][Full Text] [Related]  

  • 113. GATA3 expression in primary lung carcinomas: correlation with histopathologic features and TTF-1, napsin A, and p40 expression.
    Wang M; Chen PP; Cai G
    Hum Pathol; 2023 May; 135():93-98. PubMed ID: 36702357
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Thyroid transcription factor-1 is a marker of lung and thyroid carcinomas.
    Ordóñez NG
    Adv Anat Pathol; 2000 Mar; 7(2):123-7. PubMed ID: 10721419
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Positive immunostaining for thyroid transcription factor-1 in colorectal adenocarcinoma using the 8G7G3/1 monoclonal antibody.
    Wong NA; Kamel H; Sheffield EA; Sohail M
    J Clin Pathol; 2008 Sep; 61(9):1070-1. PubMed ID: 18755730
    [No Abstract]   [Full Text] [Related]  

  • 116. In search of the ideal immunopanel to distinguish metastatic mammary carcinoma from primary lung carcinoma: a tissue microarray study of 207 cases.
    Kawaguchi KR; Lu FI; Kaplan R; Liu YF; Chadwick P; Chen Z; Brogi E; Shin SJ
    Appl Immunohistochem Mol Morphol; 2014 Apr; 22(4):266-74. PubMed ID: 23958551
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Expression of squamous cell carcinoma markers and adenocarcinoma markers in primary pulmonary neuroendocrine carcinomas.
    Masai K; Tsuta K; Kawago M; Tatsumori T; Kinno T; Taniyama T; Yoshida A; Asamura H; Tsuda H
    Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):292-7. PubMed ID: 23060301
    [TBL] [Abstract][Full Text] [Related]  

  • 118. [Immunohistochemical detection of TTF-1 in intraoperative bioptic samples of adenocarcinoma of the lung: a year-long experience].
    Matej R; Vedralová J; Koukolík F
    Cesk Patol; 2008 Apr; 44(2):41-4. PubMed ID: 18819326
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Napsin A levels in epithelial lining fluid as a diagnostic biomarker of primary lung adenocarcinoma.
    Uchida A; Samukawa T; Kumamoto T; Ohshige M; Hatanaka K; Nakamura Y; Mizuno K; Higashimoto I; Sato M; Inoue H
    BMC Pulm Med; 2017 Dec; 17(1):195. PubMed ID: 29233112
    [TBL] [Abstract][Full Text] [Related]  

  • 120. TTF-1 positivity in metastatic colorectal carcinoma: a diagnostic pitfall in transbronchial biopsy.
    Mourra N; Bengrine-Lefevre L
    Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):574-6. PubMed ID: 20733478
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.